Frontiers in Public Health (Jan 2023)
Mpox vaccination willingness, determinants, and communication needs in gay, bisexual, and other men who have sex with men, in the context of limited vaccine availability in the Netherlands (Dutch Mpox-survey)
- Nicole H. T. M. Dukers-Muijrers,
- Nicole H. T. M. Dukers-Muijrers,
- Ymke Evers,
- Ymke Evers,
- Veja Widdershoven,
- Veja Widdershoven,
- Udi Davidovich,
- Udi Davidovich,
- Philippe C. G. Adam,
- Philippe C. G. Adam,
- Eline L. M. Op de Coul,
- Paul Zantkuijl,
- Amy Matser,
- Amy Matser,
- Amy Matser,
- Maria Prins,
- Maria Prins,
- Maria Prins,
- Henry J. C. de Vries,
- Henry J. C. de Vries,
- Henry J. C. de Vries,
- Henry J. C. de Vries,
- Casper den Heijer,
- Casper den Heijer,
- Christian J. P. A. Hoebe,
- Christian J. P. A. Hoebe,
- Christian J. P. A. Hoebe,
- Anne-Marie Niekamp,
- Anne-Marie Niekamp,
- Francine Schneider,
- Juliana Reyes-Urueña,
- Roberto Croci,
- Angelo D'Ambrosio,
- Marc van der Valk,
- Marc van der Valk,
- Dirk Posthouwer,
- Dirk Posthouwer,
- Robin Ackens,
- Henriette ter Waarbeek,
- Teymur Noori,
- Elske Hoornenborg,
- Elske Hoornenborg,
- Elske Hoornenborg
Affiliations
- Nicole H. T. M. Dukers-Muijrers
- Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands
- Nicole H. T. M. Dukers-Muijrers
- Department of Health Promotion, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands
- Ymke Evers
- Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands
- Ymke Evers
- Department of Social Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands
- Veja Widdershoven
- Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands
- Veja Widdershoven
- Department of Social Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands
- Udi Davidovich
- Department of Infectious Diseases, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, Netherlands
- Udi Davidovich
- Department of Social Psychology, University of Amsterdam, Amsterdam, Netherlands
- Philippe C. G. Adam
- Institute for Prevention and Social Research in Utrecht, Utrecht, Netherlands
- Philippe C. G. Adam
- Centre for Social Research in Health, University of New South Wales (UNSW) Sydney, Kensington, NSW, Australia
- Eline L. M. Op de Coul
- Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands
- Paul Zantkuijl
- Soa Aids Nederland, Amsterdam, Netherlands
- Amy Matser
- Department of Infectious Diseases, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, Netherlands
- Amy Matser
- 0Amsterdam University Medical Center (UMC) Location University of Amsterdam, Infectious Diseases, Amsterdam, Netherlands
- Amy Matser
- 1Amsterdam Institute for Infection and Immunity (AII), Amsterdam UMC Location University of Amsterdam, Amsterdam, Netherlands
- Maria Prins
- Department of Infectious Diseases, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, Netherlands
- Maria Prins
- 0Amsterdam University Medical Center (UMC) Location University of Amsterdam, Infectious Diseases, Amsterdam, Netherlands
- Maria Prins
- 1Amsterdam Institute for Infection and Immunity (AII), Amsterdam UMC Location University of Amsterdam, Amsterdam, Netherlands
- Henry J. C. de Vries
- Department of Infectious Diseases, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, Netherlands
- Henry J. C. de Vries
- Epidemiology and Surveillance Unit, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, Netherlands
- Henry J. C. de Vries
- 0Amsterdam University Medical Center (UMC) Location University of Amsterdam, Infectious Diseases, Amsterdam, Netherlands
- Henry J. C. de Vries
- 2Department of Dermatology, Location Academic Medical Centre, Amsterdam Institute for Infection and Immunity (AII), Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands
- Casper den Heijer
- Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands
- Casper den Heijer
- Department of Social Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands
- Christian J. P. A. Hoebe
- Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands
- Christian J. P. A. Hoebe
- Department of Social Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands
- Christian J. P. A. Hoebe
- 3Department of Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Center (MUMC+), Maastricht, Netherlands
- Anne-Marie Niekamp
- Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands
- Anne-Marie Niekamp
- Department of Social Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands
- Francine Schneider
- Department of Health Promotion, Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht, Netherlands
- Juliana Reyes-Urueña
- 4European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- Roberto Croci
- 4European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- Angelo D'Ambrosio
- 4European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- Marc van der Valk
- 0Amsterdam University Medical Center (UMC) Location University of Amsterdam, Infectious Diseases, Amsterdam, Netherlands
- Marc van der Valk
- 5Stichting HIV Monitoring, Amsterdam, Netherlands
- Dirk Posthouwer
- 3Department of Medical Microbiology, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Center (MUMC+), Maastricht, Netherlands
- Dirk Posthouwer
- 6Department of Internal Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht University Medical Center (MUMC+), Maastricht, Netherlands
- Robin Ackens
- 7Department of Integrated Care, Maastricht University Medical Centre (MUMC+), Maastricht, Netherlands
- Henriette ter Waarbeek
- Department of Sexual Health, Infectious Diseases, and Environmental Health, South Limburg Public Health Service, Heerlen, Netherlands
- Teymur Noori
- 4European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- Elske Hoornenborg
- Department of Infectious Diseases, Public Health Service of Amsterdam (GGD Amsterdam), Amsterdam, Netherlands
- Elske Hoornenborg
- 0Amsterdam University Medical Center (UMC) Location University of Amsterdam, Infectious Diseases, Amsterdam, Netherlands
- Elske Hoornenborg
- 1Amsterdam Institute for Infection and Immunity (AII), Amsterdam UMC Location University of Amsterdam, Amsterdam, Netherlands
- DOI
- https://doi.org/10.3389/fpubh.2022.1058807
- Journal volume & issue
-
Vol. 10
Abstract
IntroductionIn the 2022 multicountry mpox (formerly named monkeypox) outbreak, several countries offered primary preventive vaccination (PPV) to people at higher risk for infection. We study vaccine acceptance and its determinants, to target and tailor public health (communication-) strategies in the context of limited vaccine supply in the Netherlands.MethodsOnline survey in a convenience sample of gay, bisexual and other men who have sex with men, including transgender persons (22/07-05/09/2022, the Netherlands). We assessed determinants for being (un)willing to accept vaccination. We used multivariable multinominal regression and logistic regression analyses, calculating adjusted odds ratios (aOR) and 95 percent confidence-intervals. An open question asked for campaigning and procedural recommendations.ResultsOf respondents, 81.5% (n = 1,512/1,856) were willing to accept vaccination; this was 85.2% (799/938) in vaccination-eligible people and 77.7% (713/918) in those non-eligible. Determinants for non-acceptance included: urbanization (rural: aOR:2.2;1.2–3.7; low-urban: aOR:2.4;1.4–3.9; vs. high-urban), not knowing mpox-vaccinated persons (aOR:2.4;1.6–3.4), and lack of connection to gay/queer-community (aOR:2.0;1.5–2.7). Beliefs associated with acceptance were: perception of higher risk/severity of mpox, higher protection motivation, positive outcome expectations post vaccination, and perceived positive social norms regarding vaccination. Respondents recommended better accessible communication, delivered regularly and stigma-free, with facts on mpox, vaccination and procedures, and other preventive options. Also, they recommended, “vaccine provision also at non-clinic settings, discrete/anonymous options, self-registration” to be vaccinated and other inclusive vaccine-offers (e.g., also accessible to people not in existing patient-registries).ConclusionIn the public health response to the mpox outbreak, key is a broad and equitable access to information, and to low-threshold vaccination options for those at highest risk. Communication should be uniform and transparent and tailored to beliefs, and include other preventive options. Mpox vaccine willingness was high. Public health efforts may be strengthened in less urbanized areas and reach out to those who lack relevant (community) social network influences.
Keywords